ANRO financials
Alto Neuroscience (ANRO) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
ANRO income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $0.00 | -$661.00K | -$66.36M | -$63.24M | -2.19 |
| 2024 | $0.00 | -$502.00K | -$68.61M | -$61.43M | -2.50 |
| 2023 | $0.00 | $0.00 | -$37.81M | -$36.30M | -1.35 |
| 2022 | $0.00 | -$342.00K | -$29.19M | -$27.71M | -1.08 |
| 2021 | $210.00K | $65.00K | -$12.06M | -$9.19M | -0.36 |